{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:50:31Z","timestamp":1772239831895,"version":"3.50.1"},"reference-count":33,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Because reports on the management of recurrent granulosa cell tumor have been sparse, a consensus as to which patients should undergo surgical resection and which patients should be considered for chemotherapy has not been established. Methods: A total of 21 tumor recurrences in eight patients with granulosa cell tumor were reviewed. Results: Surgery was performed as the main treatment for 13 recurrences, while chemotherapy was chosen as the main treatment for eight recurrences. Complete tumor resection could be accomplished in 13 of 16 surgeries (81.3%), which include all the ten recurrences without involvement of liver or diaphragm and without ascites. The number of recurrent masses was significantly higher in the early recurrence group (progression free survival &lt; 2 years) than in the late recurrence (progression free survival &gt; 2 years). All cases with a solitary recurrent tumor at an extra-peritoneal site presented a significantly longer progression free survival. Conclusions: For patients with recurrent granulosa cell tumor, surgery may provide the best disease control. In cases with complete resection, the number of recurrent masses was the predictive factor for the next recurrence, and adjuvant chemotherapy might be considered in such cases.<\/jats:p>","DOI":"10.3390\/healthcare7040145","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T10:56:34Z","timestamp":1573728994000},"page":"145","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Determinants Affecting Indications for Surgery and Chemotherapy in Recurrent Ovarian Granulosa Cell Tumor"],"prefix":"10.3390","volume":"7","author":[{"given":"Hidekatsu","family":"Nakai","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-5849","authenticated-orcid":false,"given":"Kosuke","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5234-9226","authenticated-orcid":false,"given":"Hisamitsu","family":"Takaya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kotani","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Nakai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6076-9928","authenticated-orcid":false,"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriomi","family":"Matsumura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Osaka 589-8511, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kyoto Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"key":"ref_1","first-page":"CD006912","article-title":"Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)","volume":"4","author":"Gurumurthy","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ygyno.2011.03.020","article-title":"Patterns of spread and recurrence of sex cord-stromal tumors of the ovary","volume":"122","author":"Thrall","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.coc.0000037918.88451.6A","article-title":"Granulosa cell tumor of the ovary: Retrospective analysis of 45 cases","volume":"26","author":"Uygun","year":"2003","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1200\/JCO.2007.11.1005","article-title":"Management of ovarian stromal cell tumors","volume":"25","author":"Colombo","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/gyno.1994.1010","article-title":"Granulosa cell tumors of the ovary: Prognostic factors and outcome","volume":"52","author":"Risberg","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/gyno.2001.6183","article-title":"Granulosa cell tumor of the ovary: A population-based study of 37 women with stage I disease","volume":"81","author":"Lauszus","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"ref_7","unstructured":"(2019, November 12). Ovarian Cancer guideline (ver. 2. 2019). NCCN Clinical Practice guidelines in Oncology. Available online: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.critrevonc.2017.10.007","article-title":"Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects","volume":"120","author":"Boussios","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.28421","article-title":"Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group","volume":"120","author":"Brown","year":"2014","journal-title":"Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1525-1438.2007.01065.x","article-title":"Characteristics of recurrence in adult-type granulosa cell tumor","volume":"18","author":"Lee","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/gyno.1998.5304","article-title":"Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study","volume":"72","author":"Homesley","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2006.08.032","article-title":"Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women","volume":"104","author":"Zhang","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2008.12.007","article-title":"Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?","volume":"113","author":"Brown","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2003.05.038","article-title":"Ovarian sex cord-stromal tumors in children and adolescents","volume":"21","author":"Schneider","year":"2003","journal-title":"J. Clin Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2005.01.011","article-title":"The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors","volume":"97","author":"Brown","year":"2005","journal-title":"Gynecol Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.ijrobp.2009.12.005","article-title":"Role of adjuvant radiotherapy in granulosa cell tumors of the ovary","volume":"79","author":"Hauspy","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2017.05.020","article-title":"Ovarian granulosa cell tumor: A National Cancer Database study","volume":"146","author":"Seagle","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1525-1438.2007.01049.x","article-title":"Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors","volume":"18","author":"Pautier","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2014.03.573","article-title":"Hormone therapy in ovarian granulosa cell tumors: A systematic review","volume":"134","author":"Limpens","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_20","first-page":"393","article-title":"Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor","volume":"41","author":"Fishman","year":"1996","journal-title":"J. Reprod. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2006.01.050","article-title":"Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary","volume":"103","author":"Restivo","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1097-0142(197501)35:1<231::AID-CNCR2820350128>3.0.CO;2-O","article-title":"A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis","volume":"35","author":"Fox","year":"1975","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3802\/jgo.2011.22.3.214","article-title":"Prolonged survival following maximal cytoreductive effort for peritoneal metastases from recurrent granulosa cell tumor of the ovary","volume":"22","author":"Chua","year":"2011","journal-title":"J. Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3802\/jgo.2011.22.3.188","article-title":"Clinicopathologic characteristics of granulosa cell tumors of the ovary: A multicenter retrospective study","volume":"22","author":"Lee","year":"2011","journal-title":"J. Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2011.10.015","article-title":"A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors","volume":"124","author":"Sun","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2010.06.031","article-title":"Adult granulosa cell tumors of the ovary: Tumor dissemination pattern at primary and recurrent situation, surgical outcome","volume":"119","author":"Fotopoulou","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2013.04.047","article-title":"Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study","volume":"130","author":"Mangili","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/CCO.0b013e328306316f","article-title":"Management of granulosa cell tumour of the ovary","volume":"20","author":"Jamieson","year":"2008","journal-title":"Curr. Opin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygyno.2011.12.442","article-title":"Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary","volume":"125","author":"Park","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11925","DOI":"10.1007\/s00261-007-9197-1","article-title":"Recurrent ovarian granulosa cell tumors: Clinical and imaging features","volume":"33","author":"Rha","year":"2008","journal-title":"Abdom. Imaging"},{"key":"ref_31","first-page":"187","article-title":"Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer","volume":"22","author":"Wagenaar","year":"2001","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_32","first-page":"314","article-title":"Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa-cell tumor patients","volume":"14","author":"Chiara","year":"1993","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0090-8258(02)00141-5","article-title":"Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary","volume":"88","author":"Uygun","year":"2003","journal-title":"Gynecol. Oncol."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/7\/4\/145\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:34:34Z","timestamp":1760189674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/7\/4\/145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["healthcare7040145"],"URL":"https:\/\/doi.org\/10.3390\/healthcare7040145","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]}}}